Here are the DEF 14A proxy statements from dMY Squared Tech Grp A (DMYY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow DMYY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DMYY filings page.
dMY Squared Technology Group, Inc. (DMYY) has filed an amended definitive proxy statement to correct share counts and voting percentages and to solicit shareholder approval to extend the deadline to complete its Business Combination with Horizon Quantum Computing. Shareholders will vote on an Extension Amendment to move the deadline from December 29, 2025 to January 29, 2026, with up to five additional one‑month extensions to June 29, 2026, a matching Trust Agreement Amendment, and an Adjournment Proposal.
Approval of the extension items requires holders of 65% of outstanding Class A and Class B shares voting together; the Sponsor owns 1,163,484 founder shares, or 29.7%, so 1,383,434 additional shares (about 35.3%) must vote in favor. Public shareholders may redeem at an estimated $11.67 per share versus a recent $11.86 trading price, funded from approximately $27.3 million held in the trust as of the record date. If the extension is not approved and the Business Combination is not completed by the current deadline, the SPAC will redeem all public shares and proceed to liquidate.
dMY Squared Technology Group, Inc. (DMYY) is holding a virtual special meeting on December 15, 2025 for shareholders to vote on extending the deadline to complete its business combination with Horizon Quantum Computing. The board seeks approval to move the current December 29, 2025 deadline to January 29, 2026, with up to five additional one‑month extensions to June 29, 2026, and to amend the trust agreement accordingly. Shareholders can redeem their public shares for cash from the trust at an estimated $11.67 per share, based on a trust balance of about $27.3 million as of November 19, 2025, versus a market price of $11.86. If the key proposals are not approved and the business combination is not completed by the current deadline, the company will redeem all public shares and liquidate.